NCT07814001
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07814001
Title Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy (BiFAST)
Acronym BiFAST
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Hopital Henri Mondor Créteil 94010 France Details
Chu Dijon Bourgogne Dijon 21000 France Details
Chu de Lille - Hopital Claude Huriez Lille 59037 France Details
CHU de Limoges - Hopital Dupuytren Limoges 87042 France Details
Centre Léon Berard Lyon 69373 France Details
Institut Paoli Calmettes Marseille 13273 France Details
CHU de Montpellier Montpellier 34925 France Details
CHU de Nantes Nantes 44093 France Details
Hopital Necker Paris 75743 France Details
CHU de Bordeaux - Hopital Haut-Leveque Pessac 33604 France Details
CHU Lyon Sud Pierre-Bénite 69495 France Details
CHU de Poitiers - Hopital de la Miletrie Poitiers 86021 France Details
CHU Pontchaillou Rennes 35033 France Details
IUCT Oncopole Toulouse 31059 France Details
CHRU Nancy - Hopital Brabois Vandœuvre-lès-Nancy 54511 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field